A Randomized Phase Ii Study Of Atezolizumab Plus Recombinant Human Il-7 (Cyt107) Or Atezolizumab Alone In Patients With Locally Advanced Or Metastatic Urothelial Carcinoma (Muc): A Cancer Immunotherapy Trials Network Trial (Citn-14).
JOURNAL OF CLINICAL ONCOLOGY（2019）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要